Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer: A study by the Italian Trials in Medical Oncology Group

A. Di Leo, E. Bajetta, R. Buzzoni, A. M. Bochicchio, L. Nole, F. Biganzoli, M. D'Aprile, E. Veltri, G. Comella, E. Aitini, A. Di Lallo, M. Santini, S. Luccarelli, A. R. Bian

Research output: Contribution to journal › Article › peer-review

Fingerprint Dive into the research topics of 'Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer: A study by the Italian Trials in Medical Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences